Morphinsulfat Ps Pharma (Morphine Sulfate)

Morphine Sulfate, the active ingredient in Morphinsulfat Ps Pharma, is an opioid analgesic presented as an oral formulation for oral use. It treats moderate to severe pain in adult patients requiring strong analgesia. GNH USA supplies Morphinsulfat Ps Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Morphine Sulfate is an opioid analgesic used to manage pain across several clinical contexts. - Moderate to severe pain: provides effective analgesia for acute or chronic pain conditions. - Post‑operative pain: controls pain following surgical procedures. - Cancer‑related pain: alleviates malignant disease‑associated discomfort. - Acute injury pain: reduces pain from trauma or burns. - Chronic non‑cancer pain: manages persistent severe pain when other therapies are insufficient.

Morphine Sulfate may cause a range of adverse reactions, from mild to life‑threatening.

Common Side Effects: - Nausea and vomiting - Constipation - Drowsiness or sedation

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Anaphylactic or allergic reactions

When prescribing Morphine Sulfate, clinicians should observe several safety measures. - Assess pain severity and patient history before initiating therapy. - Monitor respiratory function, especially during dose titration. - Adjust dosing in patients with renal or hepatic impairment. - Avoid concurrent use with other central nervous system depressants. - Use caution in elderly patients due to increased sensitivity. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Morphine Sulfate can interact with other medicines, altering its safety or effectiveness.

Major Interactions (Avoid): - Other CNS depressants (e.g., benzodiazepines, barbiturates) – may cause profound respiratory depression. - Monoamine oxidase inhibitors – increase risk of serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin) – may raise morphine plasma levels. - Antihistamines – can enhance sedative effects. - Diuretics – may potentiate hypotensive effects.